Stock Comparison
INCY vs REGN
Incyte Corporation and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$22.73B
$66.35B
P/E (TTM)
16.1
15.5
Forward P/E
14.6
14.1
Price/Sales
4.2
4.5
Price/Book
4.0
2.1
EV/EBITDA
10.0
10.5
Dividend Yield
—
0.58%
Profitability
Net Margin
26.70%
29.60%
Operating Margin
25.60%
20.70%
Return on Equity
30.80%
14.50%
Return on Assets
13.90%
6.13%
Growth (YoY)
Revenue Growth
20.90%
19.00%
Earnings Growth
83.80%
-7.20%
Price & Risk
Beta
0.8
0.2
52-Week High
$115.56
$818.90
52-Week Low
$66.83
$516.07
Analyst Target
$110.26
$833.31
Compare INCY and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.